| Stephanie Wimpsett James, SLP | |
|
114 Woodhill Rd, Bardstown, KY 40004-9166 | |
| (502) 424-0048 | |
| Not Available |
| Full Name | Stephanie Wimpsett James |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 114 Woodhill Rd, Bardstown, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720249154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 08056 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Wimpsett James, SLP 114 Woodhill Rd, Bardstown, KY 40004-9166 Ph: (502) 424-0048 | Stephanie Wimpsett James, SLP 114 Woodhill Rd, Bardstown, KY 40004-9166 Ph: (502) 424-0048 |
News Archive
The U.S. Food and Drug Administration today updated its website www.fda.gov with information about triclosan, a common ingredient added to many consumer products to reduce or prevent bacterial contamination. It may be found in antibacterial soaps and body washes, toothpastes and some cosmetics—products regulated by the FDA.
Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.
Kaiser Health News staff writer Mary Agnes Carey reports: "In the aftermath of Republicans' election victories, defenders of the health care law are huddling - once again - in an effort to thwart GOP efforts to eviscerate the sweeping measure" (Carey, 11/11).
A new preprint research paper posted to the medRxiv* server describes a new variant B.1.620, which appeared in Lithuania, and is now prevalent in several countries in Europe, as well as in central Africa.
About one in 8,000 people have facioscapulohumeral muscular dystrophy, according to a 2014 study, which is relatively common in the world of genetic diseases.
› Verified 4 days ago
Ms. Wynna Gail Cook, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Life Care Way, Bardstown, KY 40004 Phone: 502-348-4220 | |
Mr. Matthew Harris, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 101 Isaac Greer Ct, Bardstown, KY 40004 Phone: 502-349-6214 | |
Trevor Wayne Dunn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Life Care Way, Bardstown, KY 40004 Phone: 502-348-4220 | |
Emily Hanna, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 S Salem Dr, Bardstown, KY 40004 Phone: 502-331-5478 | |
Sarah K Riggs, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 704 Bloomfield Rd, Bardstown, KY 40004 Phone: 502-331-5478 Fax: 502-348-9825 | |
Anna Reynolds Green, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5804 Loretto Rd, Bardstown, KY 40004 Phone: 502-827-3572 | |
Peggy A. Schlesinger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Welch Ln, Bardstown, KY 40004 Phone: 502-836-4414 |